# EDGAR Filing Document

**Accession Number:** 0000887733
**File Stem:** 0001157523-23-000131
**Filing Date:** 2023-1
**Character Count:** 31084
**Document Hash:** 7e0fa6abd4a6c57a3c95a15ad638639f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001157523-23-000131.hdr.sgml**: 20230131

**ACCESSION NUMBER**: 0001157523-23-000131

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20230131

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230131

**DATE AS OF CHANGE**: 20230131

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CENTRAL GARDEN & PET CO
- **CENTRAL INDEX KEY:** 0000887733
- **STANDARD INDUSTRIAL CLASSIFICATION:** WHOLESALE-MISCELLANEOUS NONDURABLE GOODS [5190]
- **IRS NUMBER:** 680275553
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-33268
- **FILM NUMBER:** 23572763

**BUSINESS ADDRESS:**
- **STREET 1:** 1340 TREAT BOULEVARD
- **STREET 2:** SUITE 600
- **CITY:** WALNUT CREEK
- **STATE:** CA
- **ZIP:** 94597
- **BUSINESS PHONE:** 9259484000

**MAIL ADDRESS:**
- **STREET 1:** 1340 TREAT BOULEVARD
- **STREET 2:** SUITE 600
- **CITY:** WALNUT CREEK
- **STATE:** CA
- **ZIP:** 94597

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CENTRAL GARDEN & PET COMPANY
- **DATE OF NAME CHANGE:** 19941019

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

#### Washington, D.C. 20549
___________

### FORM 8-K
**CURRENT REPORT**

#### Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

**Date of Report (Date of earliest event reported) <u>January 31, 2023 </u>**

**<u>Central Garden & Pet Company </u> <br> (Exact name of Registrant as Specified in its Charter)**

---

| | | |
|:---|:---|:---|
| **Delaware**<br>| **001-33268**<br>| **68-0275553**<br>|
| (State or other jurisdiction<br> of incorporation) | (Commission File<br> Number) | (IRS Employer<br> Identification Number) |

---

---

| | |
|:---|:---|
| **1340 Treat Boulevard, Suite 600, Walnut Creek, California** | **94597**  |
| (Address of principal executive offices) | (Zip Code) |

---

---

| | |
|:---|:---|
| Registrant's telephone number, including area code | **(925) 948-4000** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

(Former Name or Former Address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| <u>Title of each class</u> | <u>Trading Symbol(s)</u> | <u>Name of each exchange on which registered</u> |
| **Common Stock**<br>| **CENT**<br>| **The NASDAQ Stock Market LLC**<br>|
| **Class A Common Stock**<br>| **CENTA**<br>| **The NASDAQ Stock Market LLC**<br>|

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

#### Item 2.02 Results of Operations and Financial Condition .
On January 31, 2023, Central Garden & Pet Company issued a press release announcing its financial results for the first quarter fiscal 2023 ended December 24, 2022. A copy of the press release is attached as Exhibit 99.1.

#### Item 9.01 Financial Statements and Exhibits .
[Exhibit 99.1](a53294188_ex991.htm) [Press release dated January 31, 2023.](a53294188_ex991.htm) <br> Exhibit 104 Cover Page Interactive Data File – the cover page iXBRL tags are embedded within the Inline XBRL document.

------

#### SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CENTRAL GARDEN & PET COMPANY

---

| |
|:---|
| By: /s/ NICHOLAS LAHANAS |
| Nicholas Lahanas |
| Chief Financial Officer |
| *(Principal Financial Officer)* |
| Dated: January 31, 2023 |

---

## Exhibit 99.1

**Exhibit 99.1**<br>

**** 

<br> # **Central Garden & Pet Announces Q1 Fiscal 2023 Financial Results** 
 ***Fiscal 2023 Q1 net sales of $628 million***

 ***Fiscal 2023 Q1 loss per share of $0.16***

 ***Maintains outlook for fiscal 2023 EPS of $2.60 to $2.80***

WALNUT CREEK, Calif.--(BUSINESS WIRE)--January 31, 2023--Central Garden & Pet Company (NASDAQ: CENT) (NASDAQ: CENTA) ("Central"), a market leader in the Pet and Garden industries, today announced financial results for its fiscal 2023 first quarter ended December 24, 2022.

"We delivered first quarter results in line with our guidance which anticipated near-term challenges including the residual impact from last year's poor garden season, higher retailer inventories, softer foot traffic at garden retailers, and broadly higher input costs," said Tim Cofer, CEO of Central Garden & Pet. "Looking to the rest of the year, we assume a more normal garden season and that inventory dynamics will stabilize, and expect pricing actions and cost control to largely offset inflation. We remain confident in the competitive strength of Central, our team's ability to perform in this difficult environment and the long-term trends supporting growth in the Pet and Garden industries."

 **Fiscal 2023 First Quarter Financial Results**

Net sales were $628 million compared to $661 million a year ago, a decline of 5%.

Gross margin was 27.4% compared to 30.0% a year ago. The decline was driven primarily by the Garden segment largely due to cost inflation and unfavorable overhead absorption due to lower sales, partially offset by pricing actions.

------

Operating income was $0.4 million compared to $26 million a year ago, and operating margin was 0.1% compared to 4.0% in the prior year. The operating margin decline was primarily driven by the Garden segment largely due to cost inflation and overhead absorption pressures from lower sales, partially offset by lower commercial spend.

Net interest expense of $14 million was in line with the prior year quarter.

The Company's net loss was $8 million compared to net income of $9 million a year ago. Loss per share was $0.16 compared to earnings per share of $0.16 in the prior year quarter. Adjusted EBITDA was $29 million compared to $52 million a year ago.

The Company's effective tax rate was 24.2% compared to 20.7% in the prior year quarter.

 **Pet Segment Fiscal 2023 First Quarter Results**

Net sales for the Pet segment were $416 million compared to $436 million in the prior year, a decline of 5%. The decline was largely driven by the Company's decision to discontinue low-profit private label product lines, and lower demand for durable pet products, particularly in Aquatics.

Pet segment operating income was $40 million compared to $45 million a year ago, and operating margin was 9.5% compared to 10.4%. The decline in operating margin was mainly driven by inflation and lower sales, partially offset by pricing actions. Pet segment adjusted EBITDA was $50 million compared to $55 million a year ago.

 **Garden Segment Fiscal 2023 First Quarter Results**

Net sales for the Garden segment were $212 million compared to $225 million a year ago, a decline of 6%. Lower sales in Controls & Fertilizer were partially offset by strength in Wild Bird and Grass Seed. Net sales were unfavorably impacted by higher inventories at retail and lower foot traffic compared to a year ago.

------

Garden segment operating loss was $11 million compared to operating income of $6 million, and operating margin was (5.1)% compared to 2.7% a year ago. The decline in operating margin was mainly driven by inflation and the impact of lower sales partially offset by pricing actions. Garden segment adjusted EBITDA was $22 thousand compared to $16 million in the prior year quarter.

 **Additional Information**

The Company's cash balance at the end of the quarter was $88 million compared to $296 million a year ago, driven by inventory build over the last 12 months. Cash used by operations during the quarter was $63 million compared to $92 million a year ago. The decrease in cash used by operations was driven primarily by lower working capital requirements.

Total debt as of December 24, 2022 and December 25, 2021 was $1.2 billion. The Company's leverage ratio, as defined in the Company's credit agreement, at the end of the first quarter was 3.1x compared to 2.9x at the end of the prior year quarter. The Company repurchased approximately 251,000 shares or $9 million of its stock during the quarter.

 **Fiscal 2023 Guidance**

The Company continues to expect fiscal 2023 EPS to be $2.60 to $2.80. This outlook reflects the macroeconomic uncertainty, further cost inflation, evolving consumer behavior and unfavorable retailer inventory dynamics. The outlook includes anticipated pricing actions and productivity initiatives across the Company's portfolio to help mitigate inflation. The Company expects fiscal 2023 capital spending to be significantly below fiscal 2022 levels. Fiscal 2023 will have 53 weeks compared to 52 weeks in fiscal 2022. This outlook does not include the impact of any acquisitions or restructuring activities that may occur during fiscal 2023.

------

 **Conference Call**

The Company's senior management will hold a conference call today at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss its fiscal 2023 first quarter results and provide a general business update. The conference call and related materials can be accessed at http://ir.central.com.

Alternatively, to listen to the call by telephone, dial (201) 689-8345 (domestic and international) using confirmation #13734666.

 **About Central Garden & Pet**

Central Garden & Pet Company (NASDAQ: CENT) (NASDAQ: CENTA) understands that home is central to life and has proudly nurtured happy and healthy homes for over 40 years. With fiscal 2022 net sales of $3.3 billion, Central is on a mission to lead the future of the Pet and Garden industries. The Company's innovative and trusted products are dedicated to helping lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a leading portfolio of more than 65 high-quality brands including Amdro®, Aqueon®, Cadet®, Farnam®, Ferry~Morse®, Four Paws®, Kaytee®, K&H®, Nylabone® and Pennington®, strong manufacturing and distribution capabilities and a passionate, entrepreneurial growth culture. Central is based in Walnut Creek, California and has over 7,000 employees across North America and Europe. Visit www.central.com to learn more.

 **Safe Harbor Statement**

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this release which are not historical facts, including statements concerning further cost inflation, evolving consumer behavior and unfavorable retailer dynamics, anticipated pricing actions, productivity initiatives and reduced capital spending, and earnings guidance for fiscal 2023, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in or implied by forward-looking statements. All forward-looking statements are based upon the Company's current expectations and various assumptions. There are a number of risks and uncertainties that could cause our actual results to differ materially from the forward-looking statements contained in this release including, but not limited to, the following factors:

------

* high inflation, rising interest rates, a potential recession and other adverse macro-economic conditions, including any impact that could result if the U.S. government were to default on its debt obligations; 

* fluctuations in market prices for seeds and grains and other raw materials; 

* our inability to pass through cost increases in a timely manner; 

* fluctuations in energy prices, fuel and related petrochemical costs; 

* declines in consumer spending and increased inventory risk during economic downturns; 

* our ability to successfully manage the continuing impact of COVID-19 on our business, including but not limited to, the impact on our workforce, operations, fill rates, supply chain, demand for our products and services, and our financial
 results and condition; 

* the potential for future reductions in demand for product categories that benefited from the COVID-19 pandemic, including the potential for reduced orders as retailers work through excess inventory; 

* adverse weather conditions; 

* the success of our Central to Home strategy; 

* risks associated with our acquisition strategy, including our ability to successfully integrate acquisitions and the impact of purchase accounting on our financial results; 

* potential restructuring activities to improve long-term profitability; 

* supply chain delays and disruptions resulting in lost sales, reduced fill rates and service levels and delays in expanding capacity and automating processes; 

* seasonality and fluctuations in our operating results and cash flow; 

* supply shortages in pet birds, small animals and fish; 

* dependence on a small number of customers for a significant portion of our business; 

* consolidation trends in the retail industry; 

* risks associated with new product introductions, including the risk that our new products will not produce sufficient sales to recoup our investment; 

* competition in our industries; 

* continuing implementation of an enterprise resource planning information technology system; 

* potential environmental liabilities; 

* risk associated with international sourcing; 

* impacts of tariffs or a trade war; 

* access to and cost of additional capital; 

* potential goodwill or intangible asset impairment; 

* our dependence upon our key executives; 

* our ability to recruit and retain new members of our management team to support our growing businesses and to hire and retain employees; 

* our inability to protect our trademarks and other proprietary rights; 

* litigation and product liability claims; 

* regulatory issues; 

* the impact of product recalls; 

* potential costs and risks associated with actual or potential cyber attacks; 

* potential dilution from issuance of authorized shares; 

* the voting power associated with our Class B stock; and 

* the impact of new accounting regulations and the possibility our effective tax rate will increase as a result of future changes in the corporate tax rate or other tax law changes. 

------

These risks and others are described in the Company's Securities and Exchange Commission filings. Central undertakes no obligation to publicly update these forward-looking statements to reflect new information, subsequent events or otherwise. The Company has not filed its Form 10-Q for the fiscal quarter ended December 24, 2022, so all financial results are preliminary and subject to change.

------

---

| | | | |
|:---|:---|:---|:---|
| **CENTRAL GARDEN & PET COMPANY** <br> **CONDENSED CONSOLIDATED BALANCE SHEETS** <br> **(in thousands, except share and per share amounts, unaudited)**  | **CENTRAL GARDEN & PET COMPANY** <br> **CONDENSED CONSOLIDATED BALANCE SHEETS** <br> **(in thousands, except share and per share amounts, unaudited)**  | **CENTRAL GARDEN & PET COMPANY** <br> **CONDENSED CONSOLIDATED BALANCE SHEETS** <br> **(in thousands, except share and per share amounts, unaudited)**  | **CENTRAL GARDEN & PET COMPANY** <br> **CONDENSED CONSOLIDATED BALANCE SHEETS** <br> **(in thousands, except share and per share amounts, unaudited)**  |
| **ASSETS**  | **December 24, 2022**  | **December 25, 2021**  | **September 24, 2022**  |
| Current assets:  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Cash and cash equivalents  | $87800  | $296038  | $177442  |
| &nbsp;&nbsp;&nbsp;&nbsp; Restricted cash  | 14745  | 12913  | 14742  |
| &nbsp;&nbsp;&nbsp;&nbsp; Accounts receivable (less allowances of $26,115, $27,937 and $26,246)  | 329129  | 343659  | 376787  |
| &nbsp;&nbsp;&nbsp;&nbsp; Inventories, net  | 1024359  | 844899  | 938000  |
| &nbsp;&nbsp;&nbsp;&nbsp; Prepaid expenses and other  | 56590  | 34213  | 46883  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total current assets  | 1512623  | 1531722  | 1553854  |
| Plant, property and equipment, net  | 396675  | 340133  | 396979  |
| Goodwill  | 546436  | 369391  | 546436  |
| Other intangible assets, net  | 534207  | 130190  | 543210  |
| Operating lease right-of-use assets  | 184351  | 169709  | 186344  |
| Other assets  | 54777  | 576896  | 55179  |
| Total  | $3229069  | $3118041  | $3282002  |
| **LIABILITIES AND EQUITY**  |  |  |  |
| Current liabilities:  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Accounts payable  | $194159  | $244826  | $215681  |
| &nbsp;&nbsp;&nbsp;&nbsp; Accrued expenses  | 179231  | 225062  | 201783  |
| &nbsp;&nbsp;&nbsp;&nbsp; Current lease liabilities  | 49353  | 43051  | 48111  |
| &nbsp;&nbsp;&nbsp;&nbsp; Current portion of long-term debt  | 296  | 411  | 317  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total current liabilities  | 423039  | 513350  | 465892  |
| Long-term debt  | 1186649  | 1185057  | 1186245  |
| Long-term lease liabilities  | 145261  | 132174  | 147724  |
| Deferred income taxes and other long-term obligations  | 150676  | 58560  | 147429  |
| Equity:  |  |  |  |
| Common stock, $0.01 par value: 11,250,162, 11,335,658 and 11,296,351 shares outstanding at December 24, 2022, December 25, 2021 and September 24, 2022  | 113  | 113  | 113  |
| Class A common stock, $0.01 par value: 41,175,036, 42,205,761 and 41,336,223 shares outstanding at December 24, 2022, December 25, 2021 and September 24, 2022  | 412  | 422  | 413  |
| Class B stock, $0.01 par value: 1,602,374, 1,612,374 and 1,612,374 at December 24, 2022, December 25, 2021 and September 24, 2022  | 16  | 16  | 16  |
| Additional paid-in capital  | 585127  | 578917  | 582056  |
| Retained earnings  | 740549  | 650032  | 755253  |
| Accumulated other comprehensive loss  | (3363 )  | (1273 )  | (4145 )  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Central Garden & Pet Company shareholders' equity  | 1322854  | 1228227  | 1333706  |
| &nbsp;&nbsp;&nbsp;&nbsp; Noncontrolling interest  | 590  | 673  | 1006  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total equity  | 1323444  | 1228900  | 1334712  |
| Total  | $3229069  | $3118041  | $3282002  |

---

------

---

| | | |
|:---|:---|:---|
| **CENTRAL GARDEN & PET COMPANY** **CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS** <br> **(in thousands, except per share amounts, unaudited)**  | **CENTRAL GARDEN & PET COMPANY** **CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS** <br> **(in thousands, except per share amounts, unaudited)**  | **CENTRAL GARDEN & PET COMPANY** **CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS** <br> **(in thousands, except per share amounts, unaudited)**  |
|  | **Three Months Ended**  | **Three Months Ended**  |
|  | **December 24, 2022**  | **December 25, 2021**  |
| Net sales  | $627663  | $661398  |
| Cost of goods sold  | 455964  | 463202  |
| &nbsp;&nbsp;&nbsp;&nbsp; Gross profit  | 171699  | 198196  |
| Selling, general and administrative expenses  | 171293  | 171982  |
| &nbsp;&nbsp;&nbsp;&nbsp; Operating income  | 406  | 26214  |
| Interest expense  | (14469 ) | (14484 ) |
| Interest income  | 693  | 76  |
| Other income (expense)  | 1699  | (209 )  |
| Income (loss) before income taxes and noncontrolling interest  | (11671 ) | 11597  |
| Income tax (benefit) expense  | (2822 )  | 2401  |
| Income (loss) including noncontrolling interest  | (8849 ) | 9196  |
| Net income (loss) attributable to noncontrolling interest  | (416 )  | 187  |
| &nbsp;&nbsp;&nbsp;&nbsp; Net income (loss) attributable to Central Garden & Pet Company  | $(8433 )  | $9009  |
| Net income (loss) per share attributable to Central Garden & Pet Company:  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Basic  | $(0.16 )  | $0.17  |
| &nbsp;&nbsp;&nbsp;&nbsp; Diluted  | $(0.16 )  | $0.16  |
| Weighted average shares used in the computation of net income (loss) per share:  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Basic  | 52478  | 53491  |
| &nbsp;&nbsp;&nbsp;&nbsp; Diluted  | 52478  | 54909  |

---

------

---

| | | |
|:---|:---|:---|
| **CENTRAL GARDEN & PET COMPANY** **CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS** <br> **(in thousands, unaudited)**  | **CENTRAL GARDEN & PET COMPANY** **CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS** <br> **(in thousands, unaudited)**  | **CENTRAL GARDEN & PET COMPANY** **CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS** <br> **(in thousands, unaudited)**  |
|  | **Three Months Ended**  | **Three Months Ended**  |
|  | **December 24, 2022**  | **December 25, 2021**  |
| Cash flows from operating activities:  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Net income (loss)  | $(8849 ) | $9196  |
| &nbsp;&nbsp;&nbsp;&nbsp; Adjustments to reconcile net income (loss) to net cash used by operating activities:  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Depreciation and amortization  | 21692  | 20202  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amortization of deferred financing costs  | 675  | 640  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-cash lease expense  | 12738  | 11405  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stock-based compensation  | 6577  | 5187  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Debt extinguishment costs  | —  | 169  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Deferred income taxes  | 3260  | 2737  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other operating activities  | (35 ) | (70 ) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in assets and liabilities (excluding businesses acquired):  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accounts receivable  | 48062  | 41508  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventories  | (84689 ) | (159932 ) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prepaid expenses and other assets  | (11620 ) | (3635 ) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accounts payable  | (16107 ) | 1150  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accrued expenses  | (23049 ) | (9790 ) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other long-term obligations  | (5 ) | (53 ) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Operating lease liabilities  | (11952 )  | (11172 )  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net cash used by operating activities  | (63302 ) | (92458 ) |
| Cash flows from investing activities:  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Additions to plant, property and equipment  | (17698 ) | (24210 ) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Investments  | (250 )  | (1918 )  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net cash used in investing activities  | (17948 ) | (26128 ) |
| Cash flows from financing activities:  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Repayments of long-term debt  | (88 ) | (767 ) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Repurchase of common stock, including shares surrendered for tax withholding  | (9341 ) | (7775 ) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Payment of contingent consideration liability  | (7 ) | (89 ) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Distribution to noncontrolling interest  | —  | (806 ) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Payment of financing costs  | —  | (2153 )  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net cash used by financing activities  | (9436 ) | (11590 ) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash  | 1047  | (395 )  |
| Net decrease in cash, cash equivalents and restricted cash  | (89639 ) | (130571 ) |
| Cash, cash equivalents and restricted cash at beginning of period  | 192184  | 439522  |
| Cash, cash equivalents and restricted cash at end of period  | $102545  | $308951  |
| Supplemental information:  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cash paid for interest  | $19907  | $19750  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; New operating lease right of use assets  | $11022  | $15616  |

---

------

 **Use of Non-GAAP Financial Measures**

We report our financial results in accordance with accounting principles generally accepted in the United States (GAAP). However, to supplement the financial results prepared in accordance with GAAP, we use non-GAAP financial measures including adjusted EBITDA. Management believes non-GAAP financial measures may be useful to investors in their assessment of our ongoing operating performance and provide additional meaningful comparisons between current results and results in prior operating periods.

Adjusted EBITDA is defined by us as income before income tax, net other expense, net interest expense, depreciation and amortization and stock-based compensation (or operating income plus depreciation and amortization and stock-based compensation expense). We present adjusted EBITDA because we believe that adjusted EBITDA is a useful supplemental measure in evaluating the cash flows and performance of our business and provides greater transparency into our results of operations. Adjusted EBITDA is used by our management to perform such evaluation. Adjusted EBITDA should not be considered in isolation or as a substitute for cash flow from operations, income from operations or other income statement measures prepared in accordance with GAAP. We believe that adjusted EBITDA is frequently used by investors, securities analysts and other interested parties in their evaluation of companies, many of which present adjusted EBITDA when reporting their results. Other companies may calculate adjusted EBITDA differently and it may not be comparable.

The reconciliations of adjusted EBITDA to the most directly comparable financial measures calculated and presented in accordance with GAAP are shown in the tables below. We believe that the non-GAAP financial measures provide useful information to investors and other users of our financial statements by allowing for greater transparency in the review of our financial and operating performance. Management also uses adjusted EBITDA in making financial, operating and planning decisions and in evaluating our performance, and we believe it may be useful to investors in evaluating our financial and operating performance and the trends in our business from management's point of view. While our management believes that non-GAAP measurements are useful supplemental information, such adjusted results are not intended to replace our GAAP financial results and should be read in conjunction with those GAAP results.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Adjusted EBITDA Reconciliation** | **GAAP to Non-GAAP Reconciliation** <br> **For the Three Months Ended December 24, 2022**  | **GAAP to Non-GAAP Reconciliation** <br> **For the Three Months Ended December 24, 2022**  | **GAAP to Non-GAAP Reconciliation** <br> **For the Three Months Ended December 24, 2022**  | **GAAP to Non-GAAP Reconciliation** <br> **For the Three Months Ended December 24, 2022**  |
|  | **Pet**  | **Garden**  | **Corp**  | **Total**  |
|  | **(in thousands)**  | **(in thousands)**  | **(in thousands)**  | **(in thousands)**  |
| Net loss attributable to Central Garden & Pet Company  | $—  | $—  | $—  | $(8433 ) |
| &nbsp;&nbsp;&nbsp;&nbsp; Interest expense, net  | —  | —  | —  | 13776  |
| &nbsp;&nbsp;&nbsp;&nbsp; Other income  | —  | —  | —  | (1699 ) |
| &nbsp;&nbsp;&nbsp;&nbsp; Income tax benefit  | —  | —  | —  | (2822 ) |
| &nbsp;&nbsp;&nbsp;&nbsp; Net loss attributable to noncontrolling interest  | —  | —  | —  | (416 )  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sum of items below operating income  | —  | —  | —  | 8839  |
| Income (loss) from operations  | 39555  | (10820 ) | (28329 ) | 406  |
| Depreciation & amortization  | 10112  | 10842  | 738  | 21692  |
| Noncash stock-based compensation  | —  | —  | 6577  | 6577  |
| Adjusted EBITDA  | $49667  | $22  | $(21014 )  | $28675  |

---

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Adjusted EBITDA Reconciliation** | **GAAP to Non-GAAP Reconciliation** <br> **For the Three Months Ended December 25, 2021**  | **GAAP to Non-GAAP Reconciliation** <br> **For the Three Months Ended December 25, 2021**  | **GAAP to Non-GAAP Reconciliation** <br> **For the Three Months Ended December 25, 2021**  | **GAAP to Non-GAAP Reconciliation** <br> **For the Three Months Ended December 25, 2021**  |
|  | **Pet**  | **Garden**  | **Corp**  | **Total**  |
|  | **(in thousands)**  | **(in thousands)**  | **(in thousands)**  | **(in thousands)**  |
| Net income attributable to Central Garden & Pet Company  | $—  | $—  | $—  | $9009  |
| &nbsp;&nbsp;&nbsp;&nbsp; Interest expense, net  | —  | —  | —  | 14408  |
| &nbsp;&nbsp;&nbsp;&nbsp; Other expense  | —  | —  | —  | 209  |
| &nbsp;&nbsp;&nbsp;&nbsp; Income tax expense  | —  | —  | —  | 2401  |
| &nbsp;&nbsp;&nbsp;&nbsp; Net income attributable to noncontrolling interest  | —  | —  | —  | 187  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sum of items below operating income  | —  | —  | —  | 17205  |
| Income (loss) from operations  | 45251  | 6057  | (25094 ) | 26214  |
| Depreciation & amortization  | 9549  | 9620  | 1033  | 20202  |
| Noncash stock-based compensation  |  |  | 5187  | 5187  |
| Adjusted EBITDA  | $54800  | $15677  | $(18874 )  | $51603  |

---

## Contacts
 **Investor Relations Contact** <br> Friederike Edelmann <br> VP, Investor Relations <br> (925) 412-6726 <br> fedelmann@central.com